Storys aus Rapperswil
-
Sprache:
Englisch
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- 2Ein Dokumentmehr
Hostpoint launches free service for migrating web hosting, domains and e-mail
mehrHostpoint remains on course for very good growth in 2023
mehrHostpoint now accepting registration applications for .swiss domains from private individuals
mehrHostpoint looks back on a successful 2022 with a milestone of one million domains
mehr- 5
Hostpoint launches new e-mail offering with comprehensive office and team functions
mehr - 2
Alexander Hahn: Memory of Light – Light of Memory, 29 October 2022 – 2 April 2023, Kunstmuseum St.Gallen
Ein Dokumentmehr Hostpoint achieves record growth once again in its anniversary year 2021
mehrHostpoint is the first Swiss provider to offer telephone support on weekends
mehrHostpoint is now accepting applications to register .zuerich domains for businesses in the Zurich region
mehrHostpoint activates DNSSEC for .ch and .li domains to improve internet security in Switzerland
mehr- 5
Hostpoint celebrates its 20th anniversary and looks back on a successful history
mehr Hostpoint speeds up access to websites around the globe with DNS Anycast
mehr- 3
Hostpoint solidifies its position as the largest web hosting provider in Switzerland
mehr Hostpoint now offers protection against domain loss
mehrHostpoint enables parallel operation of Nginx and Apache in shared hosting
mehrHostpoint now supports DNSSEC and DANE
mehrNEOVII Partners with Tel Aviv University to Develop Novel COVID-19 Vaccine
Rapperswil, Switzerland and Tel Aviv, Israel (ots/PRNewswire) - The epitope-based vaccine will target the most vulnerable part of the viral spike protein Ramot , Tel Aviv University's technology transfer company, and Neovii , a Swiss-based biopharmaceutical company and a member of Israel-based Neopharm Group, announced today that they have signed a research and license ...
mehrNEOVII to Develop a Novel Vaccine for COVID-19 in an Exclusive Partnership With Tel Aviv University
Rapperswil, Switzerland (ots/PRNewswire) - Neovii, the Swiss-based biopharmaceutical company and a member of Israeli-based Neopharm Group, has signed a research and license agreement with Tel Aviv University's (TAU) RAMOT, its technology transfer company, to work in collaboration with a team led by Professor ...
mehrFree video conferences on secure Swiss servers with "Hostpoint Meet"
mehrHostpoint launches its new "Webshop" e-commerce solution
mehrHostpoint continues on a strong growth course
mehrHostpoint becomes first Swiss web hosting provider to use WhatsApp for customer service
mehrSo that all mothers and fathers can sleep better: The digital pacifier for quieter nights
mehrHostpoint launches flexible managed server solution for SMEs and web agencies
mehrHostpoint exceeds CHF 20 million in turnover
mehr- 2
Neovii Pharmaceuticals AG announces new CEO
mehr Long-term outcomes after standard graft-versus-host disease (GvHD) prophylaxis in hemopoietic cell transplantation from matched unrelated donors strongly support the use of Grafalon® as standard therapy
mehr
1